SEC Form 4 · accession 0001179110-15-007533

ABIOMED INC · ABMD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner

Michael G Howley

Officer — VP, Global Sales & Marketing

Period of report

May 7, 2015

Accepted (ET)

May 11, 2015 · 5:03 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0000815094

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I
Common Stock, $.01 par value	May 7, 2015	M	10,699	$5.23	A	96,282	D
Common Stock, $.01 par value^F4,F5	May 7, 2015	S	9,900	$69.9971	D	86,382	D
Common Stock, $.01 par value^F4,F6	May 7, 2015	S	1,528	$70.8092	D	84,854	D
Common Stock, $.01 par value^F4,F7	May 7, 2015	S	986	$71.8516	D	83,868	D
Common Stock, $.01 par value^F4,F8	May 7, 2015	S	484	$73.0029	D	83,384	D
Common Stock, $.01 par value^F4,F9	May 7, 2015	S	84	$73.7762	D	83,300	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Stock Option (Right to Buy)^F1,F2	$5.23	May 7, 2015	M	10,699	D	Mar 5, 2009	Mar 5, 2019	Common Stock	10,699	14,301	D
Stock Option (right to buy)^F1,F2	$10.03	holding	—	—	—	Jun 3, 2011	Jun 3, 2020	Common Stock	0	30,000	D
Stock Option (Right to buy)^F1,F2	$22.44	holding	—	—	—	May 22, 2013	May 22, 2022	Common Stock	0	25,000	D
Stock Option (Right to Buy)^F1,F2	$23.15	holding	—	—	—	May 14, 2014	May 14, 2023	Common Stock	0	25,000	D
Stock Option (Right to Buy)^F1,F3	$21.55	holding	—	—	—	May 14, 2015	May 14, 2024	Common Stock	0	25,000	D

Explanation of responses

F1Grant to reporting person of option to buy the number of shares of common stock set forth on Table II, Column 7, under the Abiomed, Inc. 2008 Stock Incentive Plan.
F2These options become exerciseable in annual 25% increments, commencing on the date shown forth in Table II, Column 6.
F3These options become exercisable in annual 33-1/3% increments, commencing on the date shown in Table II, Column 6.
F4Sale of common stock pursuant to reporting owner's 10b5-1 plan.
F5This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $69.5000 and $70.4900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F6This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $70.5000 and $71.3800. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F7This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $71.5200 and $72.3900. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F8This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $72.5300 and $73.4100. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.
F9This price represents the weighted average sale price of multiple transactions on the reported date at prices that ranged between $73.5300 and $73.9000. Detailed information regarding the number of shares sold at each separate price will be provided upon request by the Commission staff, the Issuer, or a security holder of the Issuer.